Rmc Co., Ltd. (“Rmc”) was OSR Health’s largest revenue line in fiscal 2025, bringing in $11.32M of $11.62M (97%).
| Ownership | FY 2025 |
|---|---|
| Rmc Co., Ltd. (“Rmc”) | $11.32M |
| Vaximm Ag (“Vaximm”) | $299.82K |
| Total | $11.62M |
OSR Health brought in $11.62M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. Rmc Co., Ltd. (“Rmc”) was the largest at $11.32M (97.4%), ahead of Vaximm Ag (“Vaximm”) at $299.82K (2.6%).
OSR Health (OSRHW) reports its revenue by ownership. In fiscal 2025, Rmc Co., Ltd. (“Rmc”) was its largest revenue line, bringing in $11.32M (97.4% of the total), followed by Vaximm Ag (“Vaximm”) at $299.82K (2.6%).
Rmc Co., Ltd. (“Rmc”) was OSR Health's largest revenue line in fiscal 2025, bringing in $11.32M, or 97.4% of the $11.62M total across its two revenue lines.
Every figure comes from OSR Health's annual financial filings, as reported. Each line keeps the name OSR Health gives it, and years follow its fiscal calendar.
OSR Health's revenue by ownership goes back to fiscal 2025, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.